USP2 and cancer: The most active anticancer pathways in adiponectin-mediated AMPK action include PI3K/AKT, ERK1/2, STAT3, β-catenin, ubiquitin carboxyl-terminal hydrolase 2 (USP2), and B-cell leukemia/lymphoma 2 (BCL-2) in this type of cancer [90].